RxDoctor Payments Data

Rachel Buttimer, DO

Family Medicine · Bettendorf, IANPI 1902474372

Payments from drug & device makers

$442in general payments, 2019–2025

Across 17 payments — averaging $25.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$141
  • Exact Sciences$76
  • Pfizer$73
  • Dexcom, Inc.$53
  • Astellas Pharma US Inc$29
  • AbbVie$24
  • plus $45 from 3 others

What the payments were for

  • Food & beverage$442100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$442 in reported general payments places this provider in the 70th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$50,173
Medicare patients
182
Services billed
518

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin44$35,862
OzempicSemaglutide29$28,665
EliquisApixaban13$14,076
Spiriva HandihalerTiotropium Bromide11$10,664
JanuviaSitagliptin Phosphate11$8,533
FarxigaDapagliflozin Propanediol13$7,657
Incruse ElliptaUmeclidinium Bromide12$5,100
Atorvastatin Calcium214$1,788
Albuterol Sulfate HfaAlbuterol Sulfate40$895
Gabapentin41$795
Lisinopril78$659
Losartan Potassium53$501
Levothyroxine Sodium93$495
Omeprazole38$491
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$485

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$17$28,66529 claims
PfizerEliquis$73$14,07613 claims
GSKIncruse Ellipta$141$5,10012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Bettendorf

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →